CCO Slideset

Session IV: Malignant Angiogenesis and Antiangiogenic Therapies

Source: 6th International Symposium on Translational Research in Oncology

Session IV: Malignant Angiogenesis and Antiangiogenic Therapies

Program Directors:

Dennis J. Slamon, MD, PhD
John Crown, MD, MPH

Faculty:

Fairooz Kabbinavar, MD

CME CREDIT INFORMATION

Release Date: 01/07/08

Expiration Date: 01/06/09

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the role of vascular endothelial growth factor in tumor growth
Discuss combinations of antiangiogenic and chemotherapeutic agents used in the treatment of cancer
Identify novel antiangiogenic agents used in the treatment of cancer

Topics covered include:

Session IV - Malignant Angiogenesis and Antiangiogenic Therapies

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.